Patients with acute myeloid leukemia (aml) have conventionally received more intense therapy than patients with myelodysplastic syndrome (mds). Treatment may include supportive care measures, such as blood transfusions. Treatment differences between mds and aml mds treatment depends highly on the risk status. The myelodysplastic syndromes (mds) and acute myeloid leukemia (aml) are a heterogeneous group of malignant clonal hematopoietic stem cell disorders. In contrast, a diagnosis of.
Treatment May Include Supportive Care Measures, Such As Blood Transfusions.
In contrast, a diagnosis of. Treatment differences between mds and aml mds treatment depends highly on the risk status. Patients with acute myeloid leukemia (aml) have conventionally received more intense therapy than patients with myelodysplastic syndrome (mds).
The Myelodysplastic Syndromes (Mds) And Acute Myeloid Leukemia (Aml) Are A Heterogeneous Group Of Malignant Clonal Hematopoietic Stem Cell Disorders.
The Myelodysplastic Syndromes (Mds) And Acute Myeloid Leukemia (Aml) Are A Heterogeneous Group Of Malignant Clonal Hematopoietic Stem Cell Disorders.
Treatment differences between mds and aml mds treatment depends highly on the risk status. In contrast, a diagnosis of. Patients with acute myeloid leukemia (aml) have conventionally received more intense therapy than patients with myelodysplastic syndrome (mds).
